<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system, characterized by demyelination, axonal damage and progressive disability. This literature review aims to provide an overview of cost-effectiveness of multiple sclerosis therapies around the world. We used PubMed and PubMed filters to identify the studies published in English related to cost-effectiveness of MS treatment from January 1, 2015 until September 8, 2020. We included a total of 39 studies out of the 224 articles that met the initial search criteria. The characteristics of each study were gathered and systematized. Due to the variety of characteristics of each study it was hard to define which therapy is the most affordable one.</p>
</abstract>

Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system, characterized by demyelination, axonal damage and progressive disability. This literature review aims to provide an overview of cost-effectiveness of multiple sclerosis therapies around the world. We used PubMed and PubMed filters to identify the studies published in English related to cost-effectiveness of MS treatment from January 1, 2015 until September 8, 2020. We included a total of 39 studies out of the 224 articles that met the initial search criteria. The characteristics of each study were gathered and systematized. Due to the variety of characteristics of each study it was hard to define which therapy is the most affordable one.

Cost-Effectiveness of Multiple Sclerosis Therapies – A Literature Review

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy

University Hospital “Alexandrovska” – Sofia

Acta Medica Bulgarica

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Cost-Effectiveness of Multiple Sclerosis Therapies \u2013 A Literature Review"}

Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system, characterized by demyelination, axonal damage and...

Cost-Effectiveness of Multiple Sclerosis Therapies – A Literature Review

Online veröffentlicht: 10. Feb. 2023

Seitenbereich: 69 - 80

Eingereicht: 29. Aug. 2022

Akzeptiert: 03. Nov. 2022

DOI: https://doi.org/10.2478/amb-2022-0046

Schlüsselwörter
multiple sclerosis, literature review, cost-effectiveness, therapy

© 2022 Y. Seitaridou et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Cost-Effectiveness of Multiple Sclerosis Therapies – A Literature Review

Online veröffentlicht: 10. Feb. 2023

Seitenbereich: 69 - 80

Eingereicht: 29. Aug. 2022

Akzeptiert: 03. Nov. 2022

DOI: https://doi.org/10.2478/amb-2022-0046

Schlüsselwörtermultiple sclerosis, literature review, cost-effectiveness, therapy

© 2022 Y. Seitaridou et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Schlüsselwörter
multiple sclerosis, literature review, cost-effectiveness, therapy